PubChem 3700821 for COVID-19

 PubChem 3700821 has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed PubChem 3700821 in detail.
Chan et al., Identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics, Acta Pharmaceutica Sinica B, doi:10.1016/j.apsb.2024.05.026